*Update: For recordings and up-to-date CME accredited course information, visit our Get CME Credits page.*
We are pleased to share that PeerView Institute in partnership with the DTRF will provide a unique MasterClass & Practicum educational symposium on desmoid tumors for members of the medical community to increase knowledge of desmoid tumors and treatment among medical professionals.
On November 17th, during the Connective Tissue Oncology Society (CTOS) Annual Meeting, the symposium entitled “On the Cusp of Change: Modernizing the Treatment of Desmoid Tumors with Novel Gamma Secretase Inhibitors” will be presented by Bernd Kasper, MD, PhD (University of Heidelberg), Mrinal Gounder, MD (Memorial Sloan Kettering Cancer Center), and Alessandro Gronchi, MD (Fondazione IRCCS Istituto Nazionale dei Tumori). The faculty will provide expert insights and practical guidance for navigating the latest treatment advances, including gamma-secretase inhibitors (GSIs), for desmoid tumors. Illustrative cases and clinical scenarios will be discussed to demonstrate the emerging role and integration of novel GSIs in real-world patient care settings.
The completion of this symposium will award participants Continuing Medical Education (CME) credits. CMEs are authorized by the American Medical Association Physician’s Recognition Award and are often required to maintain medical licenses and credentials to see patients, providing a strong incentive for physicians to maintain or increase their knowledge and skills over time.
Physicians can register at https://bit.ly/DesmoidTumors2022T.
We look forward to this educational event, and thank CTOS, PeerView, and our community for making this important project possible.